Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Rating of “Hold” from Analysts

Shares of Ardent Health, Inc. (NYSE:ARDT) have earned an average rating of “Hold” from the twelve research firms that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $15.00.

ARDT has been the subject of several analyst reports. Royal Bank Of Canada dropped their target price on Ardent Health from $21.00 to $16.00 and set an “outperform” rating for the company in a report on Friday, November 14th. Bank of America dropped their price objective on shares of Ardent Health from $12.00 to $10.00 and set an “underperform” rating for the company in a report on Thursday, November 13th. Truist Financial cut their price objective on shares of Ardent Health from $21.00 to $13.00 and set a “buy” rating for the company in a research report on Friday, November 14th. KeyCorp downgraded shares of Ardent Health from an “overweight” rating to a “sector weight” rating in a research note on Monday, November 17th. Finally, Wall Street Zen cut shares of Ardent Health from a “buy” rating to a “hold” rating in a research note on Sunday, November 23rd.

Institutional Investors Weigh In On Ardent Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Voleon Capital Management LP purchased a new stake in Ardent Health in the third quarter valued at $571,000. Verition Fund Management LLC raised its holdings in Ardent Health by 540.6% in the 3rd quarter. Verition Fund Management LLC now owns 85,561 shares of the company’s stock valued at $1,134,000 after buying an additional 72,205 shares during the period. Prelude Capital Management LLC raised its holdings in Ardent Health by 30.3% in the 3rd quarter. Prelude Capital Management LLC now owns 18,303 shares of the company’s stock valued at $243,000 after buying an additional 4,259 shares during the period. Millennium Management LLC lifted its position in Ardent Health by 6.6% in the third quarter. Millennium Management LLC now owns 1,269,605 shares of the company’s stock valued at $16,822,000 after buying an additional 78,861 shares during the last quarter. Finally, Bank of America Corp DE boosted its stake in Ardent Health by 2.5% during the third quarter. Bank of America Corp DE now owns 310,563 shares of the company’s stock worth $4,115,000 after buying an additional 7,610 shares during the period.

Ardent Health Stock Down 3.0%

ARDT stock opened at $8.78 on Friday. The company has a current ratio of 2.08, a quick ratio of 1.95 and a debt-to-equity ratio of 0.67. The firm has a 50-day moving average of $12.95 and a two-hundred day moving average of $13.00. Ardent Health has a 12 month low of $8.28 and a 12 month high of $17.34. The company has a market cap of $1.26 billion, a price-to-earnings ratio of 6.06, a PEG ratio of 7.23 and a beta of 0.44.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.10. Ardent Health had a return on equity of 19.02% and a net margin of 3.24%.The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.55 billion. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. As a group, analysts forecast that Ardent Health will post 1.23 earnings per share for the current fiscal year.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.